Skip to main content
  • FDA Allows for a New Generic Valsartan

    Approval comes in response to ARB shortage

    This story was originally published March 12, 2019. As part of MedPage Today's year-end review of 2019's top stories, we are republishing it along with an update on the latest developments in the industry-wide nitrosamine contamination problem.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details